SlideShare a Scribd company logo
1 of 10
REGISTRATION
REQUIRMENTS FOR CIS
COUNTRIES
SUBMITTED BY,
JAYA PRAKASH V,
218311.
UZBEKISTAN
• Uzbekistan: The Ministry of Health of the Republic of
Uzbekistan
I. General Documentation
• Administrative data
• Brief description of the medicinal product (SmPC), labeling
and instructions for use
• Detailed description of pharmacological surveillance and risk
management system
• Reports of independent experts on chemical, pharmaceutical
and biological documentation, pharmaco-toxicological
documentation
II. Chemical, pharmaceutical and biological documentation
• Composition
• Method of manufacturing (scheme of technological process,
draft of technological regulations)
• Methods for quality control of final product
• Stability data
• Information on dissolution profile
• Data on bioavailability, bioequivalence
III. Pharmacological and toxicological documentation
• Toxicity with single administration and administration of
repeated doses
• Data on teratogenicity, gonadotoxicity and embryotoxicity
• Data on carcinogenicity
• Additional safety information
IV. Clinical documentation
• Results of clinical trials.
• Additional information confirming effectiveness and safety,
quality, clinical effectiveness and safety.
GEORGIA
• Georgia: Ministry of Labor, Health and Social Affairs of
Georgia
• Registration requirements:
• Administrative documents
• legalized Power of Attorney from the applicant to the
representative
• legalized copy of instruction for medical use approved in
importing country together with its certified translation to
Georgian
• legalized copy of registration certificate issued by the
competent authority of importing country, where medicinal
product is registered
• legalized copy of certificate of a pharmaceutical product (CPP)
or Free Sale Certificate
• proposed mockups in Georgian and/or Russian and/or English
• specification(s) and methods of control of medicinal product
• Samples of medicinal product and standard samples
KYRGYZSTAN
• KYRGYZSTAN: ministry of health of the kyrgyz republic
• Registration requirements:
• Application for state registration
• Power of Attorney
• GMP compliance certificate
• Duly certified copy of license for production of medicines
issued by the authorized body
• Name of the medicinal product
• Description of appearance of the medicinal product for
medical use
• Physical and chemical properties
• Pharmacodynamics and pharmacokinetics
• Overdose symptoms ,relief measures in case of overdose
• Interaction with other medicinal products
• Information on possible effect of the medicinal product on the
ability to drive and operate machinery
• Shelf life and indication not to use the medicinal product after
its expiry
COMPARISON STUDY
Requirements UZBEKISTAN GEORGIA KYRGYZSTA
N
Site
registration
yes Yes yes
Stability Zone Zone I Zone I Zone I
Dossier Format Country specific CTD CTD
Language English & uzbic English &
russian
English &
kyrgyzic
THANK YOU

More Related Content

What's hot

Regulatory Strategy In Emerging Markets
Regulatory Strategy In Emerging MarketsRegulatory Strategy In Emerging Markets
Regulatory Strategy In Emerging MarketsPAREXEL International
 
Drug Registration in ASEAN Countries.pptx
Drug Registration in ASEAN Countries.pptxDrug Registration in ASEAN Countries.pptx
Drug Registration in ASEAN Countries.pptxbhavuk11
 
US FDA post approval changes
US FDA post approval changesUS FDA post approval changes
US FDA post approval changesChandra Mohan
 
Ppt 1 overview of regulatory affairs and diff bodies_august2016_final
Ppt 1 overview of regulatory affairs and diff bodies_august2016_finalPpt 1 overview of regulatory affairs and diff bodies_august2016_final
Ppt 1 overview of regulatory affairs and diff bodies_august2016_finalRajashri Survase Ojha
 
US FDA Regulatory Submissions
US FDA Regulatory SubmissionsUS FDA Regulatory Submissions
US FDA Regulatory SubmissionsChandra Mohan
 
Electronic submission PPT
Electronic submission PPTElectronic submission PPT
Electronic submission PPTDoninder Hooda
 
Regulatory affairs-Introduction to CTD
Regulatory affairs-Introduction to CTDRegulatory affairs-Introduction to CTD
Regulatory affairs-Introduction to CTDMahesh shinde
 
Product life cycle management
Product life cycle managementProduct life cycle management
Product life cycle managementVikas Rathee
 
Drug approval process in japan
Drug approval process in japanDrug approval process in japan
Drug approval process in japanManish kumar
 
Commonwealth of independent states
Commonwealth of independent statesCommonwealth of independent states
Commonwealth of independent statesgarimasaini33
 
Rest of world(row) Naveen Balaji
Rest of world(row) Naveen BalajiRest of world(row) Naveen Balaji
Rest of world(row) Naveen BalajiNaveen Balaji
 
Regulatory requirnment and approval procedure of drugs in japan ppt
Regulatory requirnment and approval procedure of drugs in japan pptRegulatory requirnment and approval procedure of drugs in japan ppt
Regulatory requirnment and approval procedure of drugs in japan pptsandeep bansal
 
Good Automated Laboratory Practices
Good Automated Laboratory PracticesGood Automated Laboratory Practices
Good Automated Laboratory PracticesSwapnil Fernandes
 
overview of Japan pharmaceutical regulatory authority - PMDA
overview of Japan  pharmaceutical regulatory authority - PMDAoverview of Japan  pharmaceutical regulatory authority - PMDA
overview of Japan pharmaceutical regulatory authority - PMDANandhanan
 
NEW DRUG APPLICATION ( NDA)
NEW DRUG APPLICATION ( NDA)NEW DRUG APPLICATION ( NDA)
NEW DRUG APPLICATION ( NDA)Suvarta Maru
 
Marketing Authorization procedures & premarket requirements sea countries
Marketing Authorization procedures & premarket requirements sea countriesMarketing Authorization procedures & premarket requirements sea countries
Marketing Authorization procedures & premarket requirements sea countriesSrinivasa Rao Moturi
 

What's hot (20)

Regulatory Strategy In Emerging Markets
Regulatory Strategy In Emerging MarketsRegulatory Strategy In Emerging Markets
Regulatory Strategy In Emerging Markets
 
Drug Registration in ASEAN Countries.pptx
Drug Registration in ASEAN Countries.pptxDrug Registration in ASEAN Countries.pptx
Drug Registration in ASEAN Countries.pptx
 
US FDA post approval changes
US FDA post approval changesUS FDA post approval changes
US FDA post approval changes
 
eCTD Submissions
eCTD SubmissionseCTD Submissions
eCTD Submissions
 
Anda ppt
Anda pptAnda ppt
Anda ppt
 
NDA/BLA/PMA and 510(k)
NDA/BLA/PMA and 510(k)NDA/BLA/PMA and 510(k)
NDA/BLA/PMA and 510(k)
 
Ppt 1 overview of regulatory affairs and diff bodies_august2016_final
Ppt 1 overview of regulatory affairs and diff bodies_august2016_finalPpt 1 overview of regulatory affairs and diff bodies_august2016_final
Ppt 1 overview of regulatory affairs and diff bodies_august2016_final
 
US FDA Regulatory Submissions
US FDA Regulatory SubmissionsUS FDA Regulatory Submissions
US FDA Regulatory Submissions
 
Electronic submission PPT
Electronic submission PPTElectronic submission PPT
Electronic submission PPT
 
Regulatory affairs-Introduction to CTD
Regulatory affairs-Introduction to CTDRegulatory affairs-Introduction to CTD
Regulatory affairs-Introduction to CTD
 
Product life cycle management
Product life cycle managementProduct life cycle management
Product life cycle management
 
eCTD Submissions
eCTD SubmissionseCTD Submissions
eCTD Submissions
 
Drug approval process in japan
Drug approval process in japanDrug approval process in japan
Drug approval process in japan
 
Commonwealth of independent states
Commonwealth of independent statesCommonwealth of independent states
Commonwealth of independent states
 
Rest of world(row) Naveen Balaji
Rest of world(row) Naveen BalajiRest of world(row) Naveen Balaji
Rest of world(row) Naveen Balaji
 
Regulatory requirnment and approval procedure of drugs in japan ppt
Regulatory requirnment and approval procedure of drugs in japan pptRegulatory requirnment and approval procedure of drugs in japan ppt
Regulatory requirnment and approval procedure of drugs in japan ppt
 
Good Automated Laboratory Practices
Good Automated Laboratory PracticesGood Automated Laboratory Practices
Good Automated Laboratory Practices
 
overview of Japan pharmaceutical regulatory authority - PMDA
overview of Japan  pharmaceutical regulatory authority - PMDAoverview of Japan  pharmaceutical regulatory authority - PMDA
overview of Japan pharmaceutical regulatory authority - PMDA
 
NEW DRUG APPLICATION ( NDA)
NEW DRUG APPLICATION ( NDA)NEW DRUG APPLICATION ( NDA)
NEW DRUG APPLICATION ( NDA)
 
Marketing Authorization procedures & premarket requirements sea countries
Marketing Authorization procedures & premarket requirements sea countriesMarketing Authorization procedures & premarket requirements sea countries
Marketing Authorization procedures & premarket requirements sea countries
 

Similar to Registration requirments for cis countries

The regulation of complementary medicines
The regulation of complementary medicinesThe regulation of complementary medicines
The regulation of complementary medicinesTGA Australia
 
121725101005-S1.pptx
121725101005-S1.pptx121725101005-S1.pptx
121725101005-S1.pptxTridevSastri1
 
Regulation in clinical trial, Schedule Y and recent amendments
Regulation in clinical trial, Schedule Y and recent amendmentsRegulation in clinical trial, Schedule Y and recent amendments
Regulation in clinical trial, Schedule Y and recent amendmentsDr. Siddhartha Dutta
 
Fda Social Media Guidance Agenda 2011
Fda Social Media Guidance Agenda 2011Fda Social Media Guidance Agenda 2011
Fda Social Media Guidance Agenda 2011biopharmaguru
 
MEDICAL DEVICE APPROVAL PROCESS IN JAPAN
MEDICAL DEVICE APPROVAL PROCESS IN JAPANMEDICAL DEVICE APPROVAL PROCESS IN JAPAN
MEDICAL DEVICE APPROVAL PROCESS IN JAPANDeveshDRA
 
Oncology Drugs: The journey From Manufacturer To The End User
Oncology Drugs: The journey From Manufacturer To The End UserOncology Drugs: The journey From Manufacturer To The End User
Oncology Drugs: The journey From Manufacturer To The End UserPharmacy @ Institut Kanser Negara
 
4.2 TT-Approved regulatory bodies and agencies.pdf
4.2 TT-Approved regulatory bodies and agencies.pdf4.2 TT-Approved regulatory bodies and agencies.pdf
4.2 TT-Approved regulatory bodies and agencies.pdfASSAM DOWN TOWN UNIVERSITY
 
Presentation: Medicinal Cannabis - what's happening?
Presentation: Medicinal Cannabis - what's happening?Presentation: Medicinal Cannabis - what's happening?
Presentation: Medicinal Cannabis - what's happening?TGA Australia
 
REGULATORY CONSIDERATIONS IN JAPAN.pptx
REGULATORY CONSIDERATIONS IN JAPAN.pptxREGULATORY CONSIDERATIONS IN JAPAN.pptx
REGULATORY CONSIDERATIONS IN JAPAN.pptxAartiVats5
 
Market authorisation checklist for brics countries
Market authorisation checklist for brics countriesMarket authorisation checklist for brics countries
Market authorisation checklist for brics countriesJAYA PRAKASH VELUCHURI
 
Drug Regulatory Systems in India
Drug Regulatory Systems in IndiaDrug Regulatory Systems in India
Drug Regulatory Systems in IndiaChandra Mohan
 

Similar to Registration requirments for cis countries (20)

5. Dr. Yuri Gamazin - Ministry of Health (Ukraine)
5. Dr. Yuri Gamazin - Ministry of Health (Ukraine)5. Dr. Yuri Gamazin - Ministry of Health (Ukraine)
5. Dr. Yuri Gamazin - Ministry of Health (Ukraine)
 
29. Prof. Sergey Tulyandin - Russian Scientific Oncology N.N. Blokhin Center
29. Prof. Sergey Tulyandin - Russian Scientific Oncology N.N. Blokhin Center29. Prof. Sergey Tulyandin - Russian Scientific Oncology N.N. Blokhin Center
29. Prof. Sergey Tulyandin - Russian Scientific Oncology N.N. Blokhin Center
 
33. Topical issues of monitoring of safety of medicines. Focus on biosimilars
33. Topical issues of monitoring of safety of medicines. Focus on biosimilars33. Topical issues of monitoring of safety of medicines. Focus on biosimilars
33. Topical issues of monitoring of safety of medicines. Focus on biosimilars
 
The regulation of complementary medicines
The regulation of complementary medicinesThe regulation of complementary medicines
The regulation of complementary medicines
 
4. Prof. Shinar Baidullaeva - National Center for Medicines, Medical Devices ...
4. Prof. Shinar Baidullaeva - National Center for Medicines, Medical Devices ...4. Prof. Shinar Baidullaeva - National Center for Medicines, Medical Devices ...
4. Prof. Shinar Baidullaeva - National Center for Medicines, Medical Devices ...
 
radc.pptx
radc.pptxradc.pptx
radc.pptx
 
121725101005-S1.pptx
121725101005-S1.pptx121725101005-S1.pptx
121725101005-S1.pptx
 
Regulation in clinical trial, Schedule Y and recent amendments
Regulation in clinical trial, Schedule Y and recent amendmentsRegulation in clinical trial, Schedule Y and recent amendments
Regulation in clinical trial, Schedule Y and recent amendments
 
Fda Social Media Guidance Agenda 2011
Fda Social Media Guidance Agenda 2011Fda Social Media Guidance Agenda 2011
Fda Social Media Guidance Agenda 2011
 
International drug regulatory affairs
International drug regulatory affairsInternational drug regulatory affairs
International drug regulatory affairs
 
MEDICAL DEVICE APPROVAL PROCESS IN JAPAN
MEDICAL DEVICE APPROVAL PROCESS IN JAPANMEDICAL DEVICE APPROVAL PROCESS IN JAPAN
MEDICAL DEVICE APPROVAL PROCESS IN JAPAN
 
Oncology Drugs: The journey From Manufacturer To The End User
Oncology Drugs: The journey From Manufacturer To The End UserOncology Drugs: The journey From Manufacturer To The End User
Oncology Drugs: The journey From Manufacturer To The End User
 
4.2 TT-Approved regulatory bodies and agencies.pdf
4.2 TT-Approved regulatory bodies and agencies.pdf4.2 TT-Approved regulatory bodies and agencies.pdf
4.2 TT-Approved regulatory bodies and agencies.pdf
 
Presentation: Medicinal Cannabis - what's happening?
Presentation: Medicinal Cannabis - what's happening?Presentation: Medicinal Cannabis - what's happening?
Presentation: Medicinal Cannabis - what's happening?
 
Pharmaceutical Regulations Outline
Pharmaceutical Regulations Outline Pharmaceutical Regulations Outline
Pharmaceutical Regulations Outline
 
REGULATORY CONSIDERATIONS IN JAPAN.pptx
REGULATORY CONSIDERATIONS IN JAPAN.pptxREGULATORY CONSIDERATIONS IN JAPAN.pptx
REGULATORY CONSIDERATIONS IN JAPAN.pptx
 
Market authorisation checklist for brics countries
Market authorisation checklist for brics countriesMarket authorisation checklist for brics countries
Market authorisation checklist for brics countries
 
Drug Regulatory Systems in India
Drug Regulatory Systems in IndiaDrug Regulatory Systems in India
Drug Regulatory Systems in India
 
Drug Regulatory Affairs
Drug Regulatory AffairsDrug Regulatory Affairs
Drug Regulatory Affairs
 
Drug regulation
Drug regulationDrug regulation
Drug regulation
 

More from JAYA PRAKASH VELUCHURI

Basics of Biologics| Biosimilars| USFDA| In View of Regulatory Point.pptx
Basics of Biologics| Biosimilars| USFDA| In View of Regulatory Point.pptxBasics of Biologics| Biosimilars| USFDA| In View of Regulatory Point.pptx
Basics of Biologics| Biosimilars| USFDA| In View of Regulatory Point.pptxJAYA PRAKASH VELUCHURI
 
HUMAN CHALLENGE STUDIES TO ACCELERATE CORONA VIRUS VACCINE LICENSURE
HUMAN CHALLENGE STUDIES TO ACCELERATE CORONA VIRUS VACCINE LICENSUREHUMAN CHALLENGE STUDIES TO ACCELERATE CORONA VIRUS VACCINE LICENSURE
HUMAN CHALLENGE STUDIES TO ACCELERATE CORONA VIRUS VACCINE LICENSUREJAYA PRAKASH VELUCHURI
 
FIXED DOSE COMBINATIONS BANNED IN INDIA
FIXED DOSE COMBINATIONS BANNED IN INDIAFIXED DOSE COMBINATIONS BANNED IN INDIA
FIXED DOSE COMBINATIONS BANNED IN INDIAJAYA PRAKASH VELUCHURI
 
AN OVERVIEW ON FIXED DOSE COMBINATIONS AND ITS REGULATIONS IN INDIA
AN OVERVIEW ON FIXED DOSE COMBINATIONS AND ITS REGULATIONS IN INDIA AN OVERVIEW ON FIXED DOSE COMBINATIONS AND ITS REGULATIONS IN INDIA
AN OVERVIEW ON FIXED DOSE COMBINATIONS AND ITS REGULATIONS IN INDIA JAYA PRAKASH VELUCHURI
 
FIXED DOSE COMBINATIONS REGULATIONS IN INDIA AND A CASE STUDY ON THE TOP SELL...
FIXED DOSE COMBINATIONS REGULATIONS IN INDIA AND A CASE STUDY ON THE TOP SELL...FIXED DOSE COMBINATIONS REGULATIONS IN INDIA AND A CASE STUDY ON THE TOP SELL...
FIXED DOSE COMBINATIONS REGULATIONS IN INDIA AND A CASE STUDY ON THE TOP SELL...JAYA PRAKASH VELUCHURI
 
IMPACT OF REGULATIONS ON MEDICAL DEVICES IN CONTEXT OF INNOVATIONS
IMPACT OF REGULATIONS ON MEDICAL DEVICES IN CONTEXT OF INNOVATIONSIMPACT OF REGULATIONS ON MEDICAL DEVICES IN CONTEXT OF INNOVATIONS
IMPACT OF REGULATIONS ON MEDICAL DEVICES IN CONTEXT OF INNOVATIONSJAYA PRAKASH VELUCHURI
 
Documentation of raw material analysis for croscarmellose sodium
Documentation of raw material analysis for croscarmellose sodiumDocumentation of raw material analysis for croscarmellose sodium
Documentation of raw material analysis for croscarmellose sodiumJAYA PRAKASH VELUCHURI
 
Regulatory guidelines for the development of biologics in
Regulatory guidelines for the development of biologics inRegulatory guidelines for the development of biologics in
Regulatory guidelines for the development of biologics inJAYA PRAKASH VELUCHURI
 

More from JAYA PRAKASH VELUCHURI (17)

Tangential Flow Filtration - PPT.pptx
Tangential Flow Filtration - PPT.pptxTangential Flow Filtration - PPT.pptx
Tangential Flow Filtration - PPT.pptx
 
Basics of Biologics| Biosimilars| USFDA| In View of Regulatory Point.pptx
Basics of Biologics| Biosimilars| USFDA| In View of Regulatory Point.pptxBasics of Biologics| Biosimilars| USFDA| In View of Regulatory Point.pptx
Basics of Biologics| Biosimilars| USFDA| In View of Regulatory Point.pptx
 
HUMAN CHALLENGE STUDIES TO ACCELERATE CORONA VIRUS VACCINE LICENSURE
HUMAN CHALLENGE STUDIES TO ACCELERATE CORONA VIRUS VACCINE LICENSUREHUMAN CHALLENGE STUDIES TO ACCELERATE CORONA VIRUS VACCINE LICENSURE
HUMAN CHALLENGE STUDIES TO ACCELERATE CORONA VIRUS VACCINE LICENSURE
 
FIXED DOSE COMBINATIONS BANNED IN INDIA
FIXED DOSE COMBINATIONS BANNED IN INDIAFIXED DOSE COMBINATIONS BANNED IN INDIA
FIXED DOSE COMBINATIONS BANNED IN INDIA
 
AN OVERVIEW ON FIXED DOSE COMBINATIONS AND ITS REGULATIONS IN INDIA
AN OVERVIEW ON FIXED DOSE COMBINATIONS AND ITS REGULATIONS IN INDIA AN OVERVIEW ON FIXED DOSE COMBINATIONS AND ITS REGULATIONS IN INDIA
AN OVERVIEW ON FIXED DOSE COMBINATIONS AND ITS REGULATIONS IN INDIA
 
HOMEOPATHY IN INDIA AND US OVERVIEW
HOMEOPATHY IN INDIA AND US OVERVIEWHOMEOPATHY IN INDIA AND US OVERVIEW
HOMEOPATHY IN INDIA AND US OVERVIEW
 
FIXED DOSE COMBINATIONS REGULATIONS IN INDIA AND A CASE STUDY ON THE TOP SELL...
FIXED DOSE COMBINATIONS REGULATIONS IN INDIA AND A CASE STUDY ON THE TOP SELL...FIXED DOSE COMBINATIONS REGULATIONS IN INDIA AND A CASE STUDY ON THE TOP SELL...
FIXED DOSE COMBINATIONS REGULATIONS IN INDIA AND A CASE STUDY ON THE TOP SELL...
 
IMPACT OF REGULATIONS ON MEDICAL DEVICES IN CONTEXT OF INNOVATIONS
IMPACT OF REGULATIONS ON MEDICAL DEVICES IN CONTEXT OF INNOVATIONSIMPACT OF REGULATIONS ON MEDICAL DEVICES IN CONTEXT OF INNOVATIONS
IMPACT OF REGULATIONS ON MEDICAL DEVICES IN CONTEXT OF INNOVATIONS
 
CASE STUDY ON CHANGE CONTROL
CASE STUDY ON CHANGE CONTROLCASE STUDY ON CHANGE CONTROL
CASE STUDY ON CHANGE CONTROL
 
Documentation of raw material analysis for croscarmellose sodium
Documentation of raw material analysis for croscarmellose sodiumDocumentation of raw material analysis for croscarmellose sodium
Documentation of raw material analysis for croscarmellose sodium
 
Response to a warning letter
Response to a warning letterResponse to a warning letter
Response to a warning letter
 
Ge health care and mri
Ge health care and mriGe health care and mri
Ge health care and mri
 
Regulatory guidelines for the development of biologics in
Regulatory guidelines for the development of biologics inRegulatory guidelines for the development of biologics in
Regulatory guidelines for the development of biologics in
 
ICH AND ICH GUIDELINES
ICH AND ICH GUIDELINESICH AND ICH GUIDELINES
ICH AND ICH GUIDELINES
 
Mutual recognition
Mutual recognitionMutual recognition
Mutual recognition
 
THIN LAYER CHROMATOGRAPHY
THIN LAYER CHROMATOGRAPHYTHIN LAYER CHROMATOGRAPHY
THIN LAYER CHROMATOGRAPHY
 
Gamp 5 overview by jaya prakash ra
Gamp 5 overview by jaya prakash raGamp 5 overview by jaya prakash ra
Gamp 5 overview by jaya prakash ra
 

Recently uploaded

FREE NURSING BUNDLE FOR NURSES.PDF by na
FREE NURSING BUNDLE FOR NURSES.PDF by naFREE NURSING BUNDLE FOR NURSES.PDF by na
FREE NURSING BUNDLE FOR NURSES.PDF by naJASISJULIANOELYNV
 
(9818099198) Call Girls In Noida Sector 14 (NOIDA ESCORTS)
(9818099198) Call Girls In Noida Sector 14 (NOIDA ESCORTS)(9818099198) Call Girls In Noida Sector 14 (NOIDA ESCORTS)
(9818099198) Call Girls In Noida Sector 14 (NOIDA ESCORTS)riyaescorts54
 
Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...Nistarini College, Purulia (W.B) India
 
Recombinant DNA technology( Transgenic plant and animal)
Recombinant DNA technology( Transgenic plant and animal)Recombinant DNA technology( Transgenic plant and animal)
Recombinant DNA technology( Transgenic plant and animal)DHURKADEVIBASKAR
 
Analytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptxAnalytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptxSwapnil Therkar
 
Transposable elements in prokaryotes.ppt
Transposable elements in prokaryotes.pptTransposable elements in prokaryotes.ppt
Transposable elements in prokaryotes.pptArshadWarsi13
 
Grafana in space: Monitoring Japan's SLIM moon lander in real time
Grafana in space: Monitoring Japan's SLIM moon lander  in real timeGrafana in space: Monitoring Japan's SLIM moon lander  in real time
Grafana in space: Monitoring Japan's SLIM moon lander in real timeSatoshi NAKAHIRA
 
Pests of soyabean_Binomics_IdentificationDr.UPR.pdf
Pests of soyabean_Binomics_IdentificationDr.UPR.pdfPests of soyabean_Binomics_IdentificationDr.UPR.pdf
Pests of soyabean_Binomics_IdentificationDr.UPR.pdfPirithiRaju
 
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptxSOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptxkessiyaTpeter
 
Call Us ≽ 9953322196 ≼ Call Girls In Lajpat Nagar (Delhi) |
Call Us ≽ 9953322196 ≼ Call Girls In Lajpat Nagar (Delhi) |Call Us ≽ 9953322196 ≼ Call Girls In Lajpat Nagar (Delhi) |
Call Us ≽ 9953322196 ≼ Call Girls In Lajpat Nagar (Delhi) |aasikanpl
 
zoogeography of pakistan.pptx fauna of Pakistan
zoogeography of pakistan.pptx fauna of Pakistanzoogeography of pakistan.pptx fauna of Pakistan
zoogeography of pakistan.pptx fauna of Pakistanzohaibmir069
 
THE ROLE OF PHARMACOGNOSY IN TRADITIONAL AND MODERN SYSTEM OF MEDICINE.pptx
THE ROLE OF PHARMACOGNOSY IN TRADITIONAL AND MODERN SYSTEM OF MEDICINE.pptxTHE ROLE OF PHARMACOGNOSY IN TRADITIONAL AND MODERN SYSTEM OF MEDICINE.pptx
THE ROLE OF PHARMACOGNOSY IN TRADITIONAL AND MODERN SYSTEM OF MEDICINE.pptxNandakishor Bhaurao Deshmukh
 
STOPPED FLOW METHOD & APPLICATION MURUGAVENI B.pptx
STOPPED FLOW METHOD & APPLICATION MURUGAVENI B.pptxSTOPPED FLOW METHOD & APPLICATION MURUGAVENI B.pptx
STOPPED FLOW METHOD & APPLICATION MURUGAVENI B.pptxMurugaveni B
 
Speech, hearing, noise, intelligibility.pptx
Speech, hearing, noise, intelligibility.pptxSpeech, hearing, noise, intelligibility.pptx
Speech, hearing, noise, intelligibility.pptxpriyankatabhane
 
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.aasikanpl
 
Solution chemistry, Moral and Normal solutions
Solution chemistry, Moral and Normal solutionsSolution chemistry, Moral and Normal solutions
Solution chemistry, Moral and Normal solutionsHajira Mahmood
 
Twin's paradox experiment is a meassurement of the extra dimensions.pptx
Twin's paradox experiment is a meassurement of the extra dimensions.pptxTwin's paradox experiment is a meassurement of the extra dimensions.pptx
Twin's paradox experiment is a meassurement of the extra dimensions.pptxEran Akiva Sinbar
 
Microphone- characteristics,carbon microphone, dynamic microphone.pptx
Microphone- characteristics,carbon microphone, dynamic microphone.pptxMicrophone- characteristics,carbon microphone, dynamic microphone.pptx
Microphone- characteristics,carbon microphone, dynamic microphone.pptxpriyankatabhane
 

Recently uploaded (20)

FREE NURSING BUNDLE FOR NURSES.PDF by na
FREE NURSING BUNDLE FOR NURSES.PDF by naFREE NURSING BUNDLE FOR NURSES.PDF by na
FREE NURSING BUNDLE FOR NURSES.PDF by na
 
(9818099198) Call Girls In Noida Sector 14 (NOIDA ESCORTS)
(9818099198) Call Girls In Noida Sector 14 (NOIDA ESCORTS)(9818099198) Call Girls In Noida Sector 14 (NOIDA ESCORTS)
(9818099198) Call Girls In Noida Sector 14 (NOIDA ESCORTS)
 
Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...
 
Recombinant DNA technology( Transgenic plant and animal)
Recombinant DNA technology( Transgenic plant and animal)Recombinant DNA technology( Transgenic plant and animal)
Recombinant DNA technology( Transgenic plant and animal)
 
Analytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptxAnalytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptx
 
Transposable elements in prokaryotes.ppt
Transposable elements in prokaryotes.pptTransposable elements in prokaryotes.ppt
Transposable elements in prokaryotes.ppt
 
Grafana in space: Monitoring Japan's SLIM moon lander in real time
Grafana in space: Monitoring Japan's SLIM moon lander  in real timeGrafana in space: Monitoring Japan's SLIM moon lander  in real time
Grafana in space: Monitoring Japan's SLIM moon lander in real time
 
Pests of soyabean_Binomics_IdentificationDr.UPR.pdf
Pests of soyabean_Binomics_IdentificationDr.UPR.pdfPests of soyabean_Binomics_IdentificationDr.UPR.pdf
Pests of soyabean_Binomics_IdentificationDr.UPR.pdf
 
Engler and Prantl system of classification in plant taxonomy
Engler and Prantl system of classification in plant taxonomyEngler and Prantl system of classification in plant taxonomy
Engler and Prantl system of classification in plant taxonomy
 
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptxSOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
 
Call Us ≽ 9953322196 ≼ Call Girls In Lajpat Nagar (Delhi) |
Call Us ≽ 9953322196 ≼ Call Girls In Lajpat Nagar (Delhi) |Call Us ≽ 9953322196 ≼ Call Girls In Lajpat Nagar (Delhi) |
Call Us ≽ 9953322196 ≼ Call Girls In Lajpat Nagar (Delhi) |
 
zoogeography of pakistan.pptx fauna of Pakistan
zoogeography of pakistan.pptx fauna of Pakistanzoogeography of pakistan.pptx fauna of Pakistan
zoogeography of pakistan.pptx fauna of Pakistan
 
THE ROLE OF PHARMACOGNOSY IN TRADITIONAL AND MODERN SYSTEM OF MEDICINE.pptx
THE ROLE OF PHARMACOGNOSY IN TRADITIONAL AND MODERN SYSTEM OF MEDICINE.pptxTHE ROLE OF PHARMACOGNOSY IN TRADITIONAL AND MODERN SYSTEM OF MEDICINE.pptx
THE ROLE OF PHARMACOGNOSY IN TRADITIONAL AND MODERN SYSTEM OF MEDICINE.pptx
 
STOPPED FLOW METHOD & APPLICATION MURUGAVENI B.pptx
STOPPED FLOW METHOD & APPLICATION MURUGAVENI B.pptxSTOPPED FLOW METHOD & APPLICATION MURUGAVENI B.pptx
STOPPED FLOW METHOD & APPLICATION MURUGAVENI B.pptx
 
Speech, hearing, noise, intelligibility.pptx
Speech, hearing, noise, intelligibility.pptxSpeech, hearing, noise, intelligibility.pptx
Speech, hearing, noise, intelligibility.pptx
 
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
 
Volatile Oils Pharmacognosy And Phytochemistry -I
Volatile Oils Pharmacognosy And Phytochemistry -IVolatile Oils Pharmacognosy And Phytochemistry -I
Volatile Oils Pharmacognosy And Phytochemistry -I
 
Solution chemistry, Moral and Normal solutions
Solution chemistry, Moral and Normal solutionsSolution chemistry, Moral and Normal solutions
Solution chemistry, Moral and Normal solutions
 
Twin's paradox experiment is a meassurement of the extra dimensions.pptx
Twin's paradox experiment is a meassurement of the extra dimensions.pptxTwin's paradox experiment is a meassurement of the extra dimensions.pptx
Twin's paradox experiment is a meassurement of the extra dimensions.pptx
 
Microphone- characteristics,carbon microphone, dynamic microphone.pptx
Microphone- characteristics,carbon microphone, dynamic microphone.pptxMicrophone- characteristics,carbon microphone, dynamic microphone.pptx
Microphone- characteristics,carbon microphone, dynamic microphone.pptx
 

Registration requirments for cis countries

  • 2. UZBEKISTAN • Uzbekistan: The Ministry of Health of the Republic of Uzbekistan I. General Documentation • Administrative data • Brief description of the medicinal product (SmPC), labeling and instructions for use • Detailed description of pharmacological surveillance and risk management system • Reports of independent experts on chemical, pharmaceutical and biological documentation, pharmaco-toxicological documentation
  • 3. II. Chemical, pharmaceutical and biological documentation • Composition • Method of manufacturing (scheme of technological process, draft of technological regulations) • Methods for quality control of final product • Stability data • Information on dissolution profile • Data on bioavailability, bioequivalence
  • 4. III. Pharmacological and toxicological documentation • Toxicity with single administration and administration of repeated doses • Data on teratogenicity, gonadotoxicity and embryotoxicity • Data on carcinogenicity • Additional safety information IV. Clinical documentation • Results of clinical trials. • Additional information confirming effectiveness and safety, quality, clinical effectiveness and safety.
  • 5. GEORGIA • Georgia: Ministry of Labor, Health and Social Affairs of Georgia • Registration requirements: • Administrative documents • legalized Power of Attorney from the applicant to the representative • legalized copy of instruction for medical use approved in importing country together with its certified translation to Georgian
  • 6. • legalized copy of registration certificate issued by the competent authority of importing country, where medicinal product is registered • legalized copy of certificate of a pharmaceutical product (CPP) or Free Sale Certificate • proposed mockups in Georgian and/or Russian and/or English • specification(s) and methods of control of medicinal product • Samples of medicinal product and standard samples
  • 7. KYRGYZSTAN • KYRGYZSTAN: ministry of health of the kyrgyz republic • Registration requirements: • Application for state registration • Power of Attorney • GMP compliance certificate • Duly certified copy of license for production of medicines issued by the authorized body • Name of the medicinal product • Description of appearance of the medicinal product for medical use
  • 8. • Physical and chemical properties • Pharmacodynamics and pharmacokinetics • Overdose symptoms ,relief measures in case of overdose • Interaction with other medicinal products • Information on possible effect of the medicinal product on the ability to drive and operate machinery • Shelf life and indication not to use the medicinal product after its expiry
  • 9. COMPARISON STUDY Requirements UZBEKISTAN GEORGIA KYRGYZSTA N Site registration yes Yes yes Stability Zone Zone I Zone I Zone I Dossier Format Country specific CTD CTD Language English & uzbic English & russian English & kyrgyzic